Report Industry Investment Ratings No relevant content provided. Core Views of the Report - For the stock index, although there is uncertainty at the end of the year due to some funds cashing in on profits, the long - term strategy is to go long on dips as policy support for the capital market remains unchanged [4]. - For treasury bonds, in the short term, the bond market is expected to fluctuate due to weak domestic demand and institutional behavior disturbances. There is an expectation of a rebound after the supply - demand relationship is repaired at the end of the year [6]. - For precious metals, with the release of overseas central bank monetary policy risks and the expectation of a loose monetary policy from the Fed, gold and silver prices are expected to remain strong. It is recommended to hold long positions [8]. - For non - ferrous metals, different metals have different outlooks. For example, copper is expected to trade in a high - level range; aluminum is expected to oscillate and gradually rise; zinc may have an upward impulse in the short term but is expected to be weak in the medium term; lead is expected to be strong in a wide - range in the short term; nickel is recommended to be observed in the short term; tin is expected to be affected by supply and demand and trade in a range; lithium carbonate is recommended to be observed due to uncertainty in supply recovery; alumina is recommended to be observed due to cost and supply factors; stainless steel is expected to continue to build a bottom in a range; and cast aluminum alloy is expected to trade in a range [11][13][16][17][19][21][22][24][25][27]. - For black building materials, steel prices are expected to remain in a bottom - range oscillation. Iron ore prices are expected to trade in a range. Glass is expected to trade in a narrow range, and soda ash is recommended to consider short positions. Manganese - silicon and silicon - iron prices are expected to be affected by the black sector and their own fundamentals. Industrial silicon and polysilicon prices are expected to follow the market with some uncertainties [30][32][34][35][38][40][43]. - For energy and chemicals, rubber is recommended for short - term operations. Crude oil is recommended to wait and see. Methanol is recommended to be observed. Urea is recommended to go long on dips. Pure benzene and styrene can be considered for long - position operations on non - integrated profits. PVC is recommended to go short on rallies. Ethylene glycol needs to guard against the risk of a rebound. PTA can be considered for long - position operations on dips. Para - xylene can be considered for long - position operations on dips. Polyethylene can go long on the LL5 - 9 spread on dips. Polypropylene is expected to be supported by a change in the cost - supply pattern in the first quarter of next year [49][51][53][56][58][61][63][65][67][69][71]. - For agricultural products, for live pigs, it is recommended to short after a consumption - driven rebound in the near term and consider reverse spreads or long positions in the far term. For eggs, it is recommended to short on rallies in the near term and pay attention to the upper pressure in the far term. For soybean and rapeseed meal, prices are expected to oscillate. For oils and fats, short - term operations based on high - frequency data are recommended. For sugar, short - term observation is recommended. For cotton, it is unlikely to have a unilateral trend [74][76][79][81][84][87]. Summaries by Directory Macro - Financial Stock Index - **Market Information**: The National Internet Information Office and the CSRC are cracking down on false information in the capital market. The National Healthcare Security Administration includes AI - assisted diagnosis in the price composition of pathological diagnosis. The Ministry of Commerce aims to boost consumption. Chinese scientists have made a breakthrough in optical computing chips [2]. - **Basis Ratio of Index Futures**: Different contracts of IF, IC, IM, and IH have specific basis ratios [3]. - **Strategy**: Although there is uncertainty at the end of the year, the long - term strategy is to go long on dips [4]. Treasury Bonds - **Market Information**: On Friday, the prices of TL, T, TF, and TS main contracts changed. In November, the number of new foreign - invested enterprises increased, but the actual use of foreign capital decreased. The Bank of Japan raised interest rates. The central bank conducted reverse repurchase operations and had a net injection of funds [5]. - **Strategy**: The bond market is expected to fluctuate in the short term due to weak domestic demand and institutional behavior disturbances. There is an expectation of a rebound after the supply - demand relationship is repaired at the end of the year [6]. Precious Metals - **Market Information**: Shanghai gold and silver prices rose. COMEX gold and silver prices are at certain levels. The Bank of Japan's interest - rate hike was less hawkish than expected, and the prices of gold and silver stabilized and rebounded. The holdings of major gold and silver ETFs increased, and the silver lease rate rose slightly [7][8]. - **Strategy**: With the release of overseas central bank monetary policy risks and the expectation of a loose monetary policy from the Fed, gold and silver prices are expected to remain strong. It is recommended to hold long positions [8]. Non - Ferrous Metals Copper - **Market Information**: The Japanese interest - rate hike led to a rise in copper prices. LME copper inventory decreased, and the domestic warehouse receipt increased. The domestic copper spot import was at a loss, and the refined - scrap copper price difference widened [10]. - **Strategy**: The Fed's loose monetary policy and the easing of concerns about the US stock AI bubble are positive. However, the supply - demand situation restricts the upward movement of copper prices. It is expected to trade in a high - level range [11]. Aluminum - **Market Information**: Overseas supply disturbances pushed up the price of LME aluminum. The position of the Shanghai aluminum contract increased, and the inventory situation changed. The domestic spot was at a discount to the futures [12]. - **Strategy**: With the decline in global aluminum inventory and positive external factors, the price of aluminum is well - supported. However, tariff and seasonal factors pose pressure. It is expected to oscillate and gradually rise [13]. Zinc - **Market Information**: The price of Shanghai zinc index rose slightly. The inventory and basis of zinc in different markets changed [14][15]. - **Strategy**: The shortage of domestic zinc ore is expected to ease. The LME zinc inventory increased, and the domestic social inventory decreased. The price is expected to be weak in the medium term but may have an upward impulse in the short term [16]. Lead - **Market Information**: The price of Shanghai lead index rose. The inventory and basis of lead in different markets changed [17]. - **Strategy**: The supply of domestic lead ingots is expected to tighten, and the inventory is at a relatively low level. The price is expected to be strong in a wide - range in the short term [17]. Nickel - **Market Information**: The price of Shanghai nickel rebounded significantly. The spot premium and cost of nickel remained stable, while the price of nickel iron declined slightly [18]. - **Strategy**: The oversupply pressure of nickel is still large. It is recommended to observe in the short term [19]. Tin - **Market Information**: The price of Shanghai tin rose. The production of tin smelters in Yunnan and Jiangxi faced different problems, and the demand was affected by high prices [20]. - **Strategy**: The supply and demand of tin are both weak. The price is expected to follow the market with some uncertainties [21]. Lithium Carbonate - **Market Information**: The price of lithium carbonate rose. The price of lithium concentrate decreased slightly [22]. - **Strategy**: The short - term supply recovery expectation was falsified. It is recommended to observe due to the uncertainty of the mid - term fundamentals [22]. Alumina - **Market Information**: The price of the alumina index decreased. The domestic spot was at a premium to the futures, and the overseas price remained stable [23]. - **Strategy**: With the recovery of ore supply and over - capacity in the smelting end, it is recommended to observe due to cost and supply factors [24]. Stainless Steel - **Market Information**: The price of the stainless - steel contract rose. The spot price increased, and the inventory decreased [24]. - **Strategy**: The spot market is inactive, and the price is expected to continue to build a bottom in a range [25]. Cast Aluminum Alloy - **Market Information**: The price of the cast - aluminum alloy contract rose. The position and inventory changed [26]. - **Strategy**: With a strong cost and supply disturbances, but weak demand and delivery pressure, the price is expected to trade in a range [27]. Black Building Materials Steel - **Market Information**: The prices of rebar and hot - rolled coil decreased slightly. The warehouse receipt and position of the contracts changed. The spot prices in different regions remained stable or decreased slightly [29]. - **Strategy**: Terminal demand is weak, and the inventory pressure of hot - rolled coils is relatively high. Steel prices are expected to remain in a bottom - range oscillation. The export license policy may have a short - term impact [30]. Iron Ore - **Market Information**: The price of the iron - ore contract rose slightly. The spot price and basis changed [31]. - **Strategy**: The supply of iron ore is increasing, and the demand is decreasing. The port inventory is increasing, and the steel - mill inventory is at a low level. The price is expected to trade in a range [32]. Glass and Soda Ash - **Market Information**: The price of the glass contract decreased. The inventory increased, and the positions of long and short decreased. The price of the soda - ash contract decreased. The inventory increased, and the positions of long and short decreased [33][35]. - **Strategy**: The demand for glass is weak, and it is expected to trade in a narrow range. The demand for soda ash is weak, and it is recommended to consider short positions [34][35]. Manganese - Silicon and Silicon - Iron - **Market Information**: The prices of manganese - silicon and silicon - iron contracts rose. The spot prices increased, and the basis changed [36]. - **Strategy**: The prices are expected to be affected by the black sector and their own fundamentals. Attention should be paid to the cost of manganese ore and the supply contraction of silicon - iron [38]. Industrial Silicon and Polysilicon - **Market Information**: The price of the industrial - silicon contract rose. The spot price remained stable, and the basis changed. The price of the polysilicon contract rose. The spot price remained stable, and the basis changed [39][41]. - **Strategy**: The price of industrial silicon is expected to follow the market with some uncertainties. The price of polysilicon is expected to be unstable, and attention should be paid to spot transactions and warehouse - receipt registration [40][43]. Energy and Chemicals Rubber - **Market Information**: The price of rubber oscillated weakly. The开工 rate of tire enterprises changed, and the inventory increased [45][47]. - **Strategy**: A neutral approach is recommended for short - term operations. A hedging strategy of buying RU2601 and selling RU2609 is recommended [49]. Crude Oil - **Market Information**: The price of the INE crude - oil contract decreased. The inventory of refined oil products changed [50]. - **Strategy**: A low - buying and high - selling range strategy is maintained, but it is recommended to wait and see for now [51]. Methanol - **Market Information**: The regional spot and futures prices of methanol changed. The MTO profit decreased [52]. - **Strategy**: After the realization of positive factors, the market is in a short - term consolidation. The port pressure remains, and it is recommended to observe [53]. Urea - **Market Information**: The regional spot and futures prices of urea changed. The basis decreased [54][55]. - **Strategy**: The supply is decreasing, and the demand is increasing. The price is expected to build a bottom in a range. It is recommended to go long on dips [56]. Pure Benzene and Styrene - **Market Information**: The prices and basis of pure benzene and styrene changed. The supply and demand indicators also changed [57]. - **Strategy**: It is possible to go long on non - integrated profits of styrene before the first quarter of next year [58]. PVC - **Market Information**: The price of the PVC contract decreased. The spot price, basis, and cost changed. The开工 rate and inventory also changed [59]. - **Strategy**: The domestic supply is strong, and the demand is weak. It is recommended to go short on rallies [61]. Ethylene Glycol - **Market Information**: The price of the ethylene - glycol contract decreased. The supply, demand, and inventory indicators changed [62]. - **Strategy**: The supply is expected to improve, but the inventory is increasing. It is necessary to guard against the risk of a rebound [63]. PTA - **Market Information**: The price of the PTA contract increased. The supply, demand, and inventory indicators changed [64]. - **Strategy**: The supply is in high - level maintenance, and the demand is affected by the off - season. It is recommended to consider long - position operations on dips [65]. Para - Xylene - **Market Information**: The price of the para - xylene contract increased. The supply, demand, and inventory indicators changed [66]. - **Strategy**: The supply is high, and the demand is weak. It is recommended to consider long - position operations on dips [67]. Polyethylene - **Market Information**: The price of the polyethylene contract decreased. The spot price, basis, and inventory changed [68]. - **Strategy**: The price is expected to be supported by a change in the cost - supply pattern. It can go long on the LL5 - 9 spread on dips [69]. Polypropylene - **Market Information**: The price of the polypropylene contract decreased. The spot price, basis, and inventory changed [70]. - **Strategy**: The supply and demand are both weak, and the inventory pressure is high. It is expected to be supported by a change in the cost - supply pattern in the first quarter of next year [71]. Agricultural Products Live Pigs - **Market Information**: The price of live pigs decreased. The supply is expected to be sufficient, and the demand may decline slightly [73]. - **Strategy**: It is recommended to short after a consumption - driven rebound in the near term and consider reverse spreads or long positions in the far term [74]. Eggs - **Market Information**: The price of eggs remained stable with a slight decline in some areas. The supply is sufficient, and the demand is general [75]. - **Strategy**: It is recommended to short on rallies in the near term and pay attention to the upper pressure in the far term [76]. Soybean and Rapeseed Meal - **Market Information**: The price of CBOT soybeans decreased. The domestic spot price of soybean meal changed slightly. The supply and demand indicators changed [77][78]. - **Strategy**: The price is expected to oscillate due to cost support and pressure on crushing margins [79]. Oils and Fats - **Market Information**: The price of domestic oils and fats decreased. The production and export data of Malaysian palm oil changed. The inventory and consumption data of Indian vegetable oils changed [80]. - **Strategy**: Short - term operations based on high - frequency data are recommended [81]. Sugar - **Market Information**: The price of the sugar contract decreased. The spot price decreased. The import and production data of sugar changed [82][83]. - **Strategy**: Short - term observation is recommended due to the expected increase in global supply [84]. Cotton - **Market Information**: The price of the cotton contract increased slightly. The spot price increased. The import, production, and inventory data of cotton changed [85][86]. - **Strategy**: It is unlikely to have a unilateral trend due to uncertain policies and hedging pressure [87].

Investment Rating - The industry investment rating is "Outperform the Market" (预计6个月内，行业指数表现强于市场表现5%以上) [32] Core Insights - The National Healthcare Security Administration issued the "Guidelines for the Establishment of Pricing Projects for Pathological Medical Services (Trial)," which aims to systematically reshape existing pathological pricing projects, focusing on biopsy sampling, sample processing, slice replication, pathological staining, and diagnosis, establishing 28 pricing projects, 3 additional charges, and 2 expansion items. This refined pricing is expected to promote high-quality development in pathology and create new scenarios for the application of artificial intelligence-assisted technologies [4] - The guidelines will standardize the charging for digital pathological slices, solidifying the data foundation for large-scale applications of new scenarios. It includes "providing digital images of pathological slices" as an essential item for various pathological services, reflecting the costs of related resource consumption in pricing [4] - The guidelines also explore suitable forms to respond to the charging demands of artificial intelligence assistance, promoting the early application of AI in the pathology field by including "AI-assisted diagnosis" as an expansion item in the pricing structure [4] - The establishment of separate pricing projects for pathological diagnosis and sample testing emphasizes the value of technical services and supports precise medication guidance [4] Summary by Sections Investment Strategy - The report suggests focusing on innovative pharmaceutical companies with rich pipeline layouts, such as Heng Rui Medicine, BeiGene, and China National Pharmaceutical Group. It also highlights companies with significant single-product potential and price revaluation prospects, such as 3SBio, Kaineng Technology, and Qianhong Pharmaceutical. Additionally, it recommends companies leading in cutting-edge technology platform layouts, such as Dongcheng Pharmaceutical, Yuanda Pharmaceutical, and Kelun-Biotech [6] - In the CXO sector, it notes that R&D investment in pharmaceuticals is steadily increasing, and the innovation environment is expected to improve, suggesting attention to companies like WuXi AppTec, WuXi Biologics, and Boteng Co. [6] - For upstream companies, it indicates that quality enterprises are entering a harvest period with overseas layouts, recommending attention to Aopumai, Baipusais, and Baiyao [6] - In the medical device sector, it mentions that ongoing procurement will continue to advance, with equipment companies gradually digesting channel inventory, suggesting attention to Mindray Medical, United Imaging, and Kaili Medical [6] Industry News - The report highlights several key developments in the industry, including Takeda's TYK2 drug achieving positive results in Phase III studies, Baiyatai's anti-VEGF monoclonal antibody application for market approval, Sanofi's innovative therapy for hypertrophic cardiomyopathy receiving domestic approval, and Enhertu (Trastuzumab Deruxtecan) gaining FDA approval for a new indication [8][12][15][16]

（来源：新安晚报） 转自：新安晚报 国家医保局12月19日发布《病理类医疗服务价格项目立项指南（试行）》，明确将"人工智能辅助诊 断"列为病理诊断的扩展项，将人工智能辅助诊断纳入病理诊断价格项目的价格构成。 为推动人工智能在病理领域的应用，立项指南指导各地在定价时关注人工智能辅助诊断的相关资源投入 成本，在价格水平上进行整体调节和引导，为人工智能辅助诊断技术应用理顺收费路径。医疗机构可自 行决定是否选用人工智能辅助诊断技术、自行决定选用哪家企业的产品，具体收益分配由医疗机构与企 业自行协商确定。 临床检查中，影像、检验、病理是患者最常接触的三类检查方式。其中，病理被认为是医学诊断的"金 标准"，依托细胞病理、组织病理及分子病理等技术平台，通过对病变组织与细胞的精准分析，明确疾 病类型、肿瘤分型及关键基因突变，为临床诊疗方案的制定提供关键依据。 下一步，国家医保局将指导各省医保局参考此次立项指南，制定全省统一的价格基准，由具有价格管理 权限的统筹地区对照全省价格基准，上下浮动确定实际执行的价格水平。据新华社电 聚焦活检取样、样本处理、切片复制、病理染色、病理诊断等环节，立项指南将已有价格项目规范整合 为28项、 ...

新华社北京12月19日电（记者彭韵佳）国家医保局12月19日发布《病理类医疗服务价格项目立项指南 （试行）》，明确将"人工智能辅助诊断"列为病理诊断的扩展项，将人工智能辅助诊断纳入病理诊断价 格项目的价格构成。 ...

Core Insights - The article highlights the digital transformation of the Zhashui County People's Hospital in Shaanxi Province, driven by the "Internet + Healthcare" concept and supported by the Jiangsu-Shaanxi cooperation model [1][2] Group 1: Internet Hospital Development - Zhashui County launched its first county-level internet hospital in October 2024, integrating services such as appointment registration, online diagnosis, and health checkups, with over 330 registered medical staff and more than 2,000 users [2] - The establishment of the internet hospital was facilitated by a cooperation agreement signed in December 2022 between Nanjing Drum Tower Hospital and Zhashui County People's Hospital, allowing for the transfer of successful operational models and technical standards [2] Group 2: Remote Diagnosis Initiatives - The "Heart ECG Network" project was initiated in June 2024, creating a remote diagnosis platform for ECGs that covers all town health centers and administrative villages, with over 10,000 diagnoses completed [3] - The project received an investment of over 400,000 yuan, supported by Jiangsu's cooperation funds and technical assistance from Jiangsu hospitals, significantly enhancing local medical staff's ECG interpretation skills [3] Group 3: Imaging Services Enhancement - Zhashui County People's Hospital introduced cloud-based imaging services, allowing patients to access and share high-definition images via QR codes, and connected to a remote imaging consultation platform with Nanjing Drum Tower Hospital [4] - A collaborative mechanism was established with top hospitals in Jiangsu, enabling local doctors to participate in daily image review meetings and receive remote consultations for complex cases, thereby improving diagnostic accuracy [4] Group 4: Future Prospects - The hospital plans to expand its internet hospital functionalities, deepen remote medical services, and explore AI-assisted diagnosis, demonstrating the effectiveness of the Jiangsu-Shaanxi cooperation in driving grassroots medical innovation [5] - The ongoing collaboration is seen as a powerful engine for promoting balanced regional healthcare development and advancing the health of communities in the Qinba Mountain area [5]

Core Insights - The Dongying Municipal Medical Insurance Bureau has implemented new medical service pricing guidelines, focusing on enhancing the public welfare aspect of basic medical services while ensuring the stability of public burden and the sustainability of public medical institutions [3][4] Group 1: Implementation of Pricing Guidelines - In 2023, the Dongying Municipal Medical Insurance Bureau has introduced six major categories of pricing guidelines, resulting in a total of 145 new pricing projects and the abolition of 456 old pricing projects [3] - The new guidelines emphasize the adjustment of prices for organ transplantation and nursing services, with significant increases, while some categories like mental health assessments have seen slight decreases [3] Group 2: Service Content and Focus - The new guidelines are service output-oriented, differentiating projects based on human resource consumption and technical labor input, while also considering patient needs and emerging industry developments [3] - New services have been established, such as home service fees and specialized care for premature infants, to enhance the quality of medical services for children and the elderly [3] Group 3: Future Directions - The Dongying Municipal Medical Insurance Bureau plans to continue its role in managing medical service prices and will work on subsequent batches of pricing guidelines to promote and guide the healthy development of the medical industry [4]

Core Viewpoint - The article discusses the recent adjustments in medical service pricing for radiological examinations in China, particularly focusing on the significant price reductions for high-cost imaging services like PET/CT, driven by national healthcare reforms and the push for digital transformation in medical imaging [1][3][7]. Pricing Adjustments - The National Healthcare Security Administration initiated a standardized pricing reform for radiological services, leading to price adjustments across multiple provinces starting in 2025 [1][3]. - In Shaanxi Province, new regulations have been implemented, resulting in substantial price reductions for various imaging services, with PET/CT prices dropping from over 4200 yuan to 2450 yuan, a decrease of over 40% [2][3][5]. Digital Transformation - The new pricing regulations eliminate the bundling of physical film costs with examination fees, promoting cloud storage and cross-institution sharing of imaging results [4][7]. - Patients can access digital images conveniently through mobile devices, and if public medical institutions do not provide compliant digital imaging services, they will incur a price reduction of 5 yuan per examination [4][7]. Market Dynamics - The price adjustments are closely linked to the centralized procurement of medical equipment and the acceleration of domestic alternatives, which have significantly lowered procurement costs for hospitals [7][8]. - The price of CT machines has decreased from 5-8 million yuan in 2015 to 3-5 million yuan today, reflecting a 40% reduction, with lower-end products seeing price drops of over 70% [7][8]. Financial Implications - The reduction in film and repeat examination costs could potentially free up 50 billion yuan annually in resource-rich provinces, translating to over 800 billion yuan nationwide, enhancing the financial flexibility of healthcare funding [8]. - The new pricing structure emphasizes examination effectiveness rather than equipment specifications, aiming to align costs with clinical value [8]. Future Outlook - The article suggests that medical device companies must adapt to the new pricing pressures by enhancing service value and aligning with policy changes, rather than relying solely on technical specifications to compete in the market [8].

Core Points - The article highlights the growing healthcare collaboration between China and Mongolia, particularly through the medical services provided in Urat Qiangqi, Inner Mongolia, to Mongolian patients [10][21][22] - It emphasizes the importance of the Gankimoudou Port as a significant trade and healthcare access point between the two countries, facilitating cross-border medical services [20][22] Group 1: Healthcare Services - Urat Qiangqi has established a close-knit medical community to provide quality healthcare services to both Chinese and Mongolian patients, with a focus on integrating traditional Mongolian medicine and Western medical practices [21][22] - The Urat Qiangqi Mongolian Medicine Hospital has treated thousands of Mongolian patients, with a reported 8,430 patients receiving care from May 2015 to the end of 2024 [21] - The article describes the case of a Mongolian patient, Sumia, who traveled to Urat Qiangqi for treatment, highlighting the challenges and the quality of care received [15][16] Group 2: Cross-Border Collaboration - The article discusses the historical context of medical collaboration, with Chinese doctors providing medical assistance in Mongolia for many years, fostering goodwill and friendship [17][18] - The Gankimoudou Port is noted as the largest road port for trade between China and Mongolia, with a significant increase in cargo volume, which also supports the influx of patients seeking medical care [20][22] - The construction of the Gankimoudou to Gashun Suhait Railway is expected to enhance transportation capacity, further facilitating cross-border healthcare access and trade [22]

Core Insights - The online consultation market in China is experiencing explosive growth, driven by the fast-paced modern lifestyle and increasing health awareness among the population. The market size is projected to reach 69.54 billion yuan in 2024, reflecting a year-on-year increase of 23.4% [1][11]. Online Consultation Industry Overview - Online consultation refers to a medical service model that allows patients to communicate with doctors remotely via internet platforms, breaking geographical barriers and utilizing various communication methods such as video, text, and voice [2]. - The industry has evolved through three main stages: the nascent phase (2000-2014), the initiation phase (2015-2016), and the rapid development phase (2017-present) [4][5]. Industry Development and Trends - The COVID-19 pandemic has accelerated the acceptance of online consultations, leading to increased government support and policy initiatives aimed at promoting remote medical services [6]. - The number of healthcare institutions in China is projected to grow from 1,007,600 in 2019 to 1,093,600 in 2024, driven by rising healthcare demands due to an aging population and chronic disease prevalence [8][9]. Competitive Landscape - The online consultation industry features a diverse competitive landscape, including comprehensive medical platforms, specialized medical platforms, and pharmaceutical e-commerce platforms. Major players include Ping An Good Doctor, JD Health, and Alibaba Health [11][12]. Future Development Directions - The integration of advanced technologies such as artificial intelligence and big data is expected to enhance the efficiency and accuracy of online consultation services [13]. - Establishing a robust regulatory framework for medical service quality is crucial for the sustainable development of the online consultation industry, addressing challenges such as verifying medical qualifications and ensuring accurate diagnoses [14]. - Data security and privacy protection are paramount, as the industry handles sensitive patient information. Strengthening data management practices and employing advanced encryption technologies are essential for safeguarding patient data [15].

Core Viewpoint - The Chinese government is providing technical assistance for the prevention and control of schistosomiasis in Zanzibar, Tanzania, through a newly arrived expert group, aiming to achieve the elimination of the disease and contribute to global tropical disease control efforts [1]. Group 1 - The expert group, led by Wang Wei, has arrived in Zanzibar to implement comprehensive prevention measures based on previous epidemiological surveys [1]. - The project includes safe water supply, control of intermediate hosts, population intervention, and health education in the demonstration area of Pemba Island [1]. - Advanced technologies such as nucleic acid testing and AI-assisted diagnosis will be promoted, along with the introduction of environmental DNA (eDNA) monitoring for early warning and dynamic assessment of high-risk water bodies [1]. Group 2 - The cooperation on schistosomiasis prevention in Tanzania began with a memorandum signed by China at the World Health Assembly in 2014, committing to provide funding and technical support [1]. - The first expert group from Jiangsu Province arrived in Pemba Island in 2017, marking the start of China's involvement in this health initiative [1]. - The second phase of the technical assistance project for schistosomiasis prevention in Zanzibar was launched in 2023 [1].